Dynatronics (DYNT) Competitors $0.08 0.00 (-3.53%) As of 10:43 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsSEC FilingsTrendsBuy This Stock DYNT vs. GCTK, HSCS, QNRX, VERO, NAOV, CTCX, TTOO, TIVC, BBLG, and NDRAShould you be buying Dynatronics stock or one of its competitors? The main competitors of Dynatronics include GlucoTrack (GCTK), Heart Test Laboratories (HSCS), Quoin Pharmaceuticals (QNRX), Venus Concept (VERO), NanoVibronix (NAOV), Carmell (CTCX), T2 Biosystems (TTOO), Tivic Health Systems (TIVC), Bone Biologics (BBLG), and ENDRA Life Sciences (NDRA). These companies are all part of the "medical equipment" industry. Dynatronics vs. GlucoTrack Heart Test Laboratories Quoin Pharmaceuticals Venus Concept NanoVibronix Carmell T2 Biosystems Tivic Health Systems Bone Biologics ENDRA Life Sciences GlucoTrack (NASDAQ:GCTK) and Dynatronics (NASDAQ:DYNT) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, community ranking, dividends, institutional ownership, media sentiment, valuation and risk. Which has more risk and volatility, GCTK or DYNT? GlucoTrack has a beta of -0.14, suggesting that its stock price is 114% less volatile than the S&P 500. Comparatively, Dynatronics has a beta of 0.45, suggesting that its stock price is 55% less volatile than the S&P 500. Do institutionals and insiders believe in GCTK or DYNT? 10.9% of GlucoTrack shares are held by institutional investors. Comparatively, 4.2% of Dynatronics shares are held by institutional investors. 46.5% of GlucoTrack shares are held by company insiders. Comparatively, 8.0% of Dynatronics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community favor GCTK or DYNT? Dynatronics received 309 more outperform votes than GlucoTrack when rated by MarketBeat users. CompanyUnderperformOutperformGlucoTrackN/AN/ADynatronicsOutperform Votes30947.03% Underperform Votes34852.97% Which has better valuation & earnings, GCTK or DYNT? Dynatronics has higher revenue and earnings than GlucoTrack. Dynatronics is trading at a lower price-to-earnings ratio than GlucoTrack, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlucoTrackN/AN/A-$7.10M-$56.600.00Dynatronics$33.60M0.03-$2.70M-$0.78-0.11 Does the media refer more to GCTK or DYNT? In the previous week, GlucoTrack had 1 more articles in the media than Dynatronics. MarketBeat recorded 1 mentions for GlucoTrack and 0 mentions for Dynatronics. GlucoTrack's average media sentiment score of 0.22 beat Dynatronics' score of 0.00 indicating that GlucoTrack is being referred to more favorably in the media. Company Overall Sentiment GlucoTrack Neutral Dynatronics Neutral Is GCTK or DYNT more profitable? GlucoTrack has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Dynatronics' return on equity of -41.81% beat GlucoTrack's return on equity.Company Net Margins Return on Equity Return on Assets GlucoTrackN/A -826.43% -707.26% Dynatronics -8.35%-41.81%-9.56% SummaryDynatronics beats GlucoTrack on 7 of the 13 factors compared between the two stocks. Get Dynatronics News Delivered to You Automatically Sign up to receive the latest news and ratings for DYNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DYNT vs. The Competition Export to ExcelMetricDynatronicsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$871,000.00$4.44B$5.35B$8.44BDividend YieldN/A43.63%5.21%4.11%P/E Ratio-0.1029.3426.9119.77Price / Sales0.0366.00390.06119.10Price / CashN/A51.0838.2534.62Price / Book0.146.226.794.52Net Income-$2.70M$67.60M$3.23B$248.23M7 Day PerformanceN/A-0.44%1.99%0.77%1 Month PerformanceN/A18.25%11.45%13.45%1 Year PerformanceN/A21.27%17.35%7.67% Dynatronics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DYNTDynatronicsN/A$0.08-3.5%N/A-80.2%$871,000.00$33.60M-0.10200Analyst ForecastGap DownGCTKGlucoTrack0.9958 of 5 stars$0.15-4.1%N/A-99.7%$3.81MN/A0.005Positive NewsGap UpHSCSHeart Test Laboratories2.4074 of 5 stars$3.47+1.2%$13.00+274.6%-30.7%$3.75M$14,700.00-0.4410Gap UpQNRXQuoin Pharmaceuticals0.356 of 5 stars$6.12-1.1%N/A-67.7%$3.60MN/A-1.514VEROVenus Concept0.8602 of 5 stars$2.49+2.5%N/A-66.7%$3.55M$64.83M-0.31410Positive NewsEarnings ReportAnalyst DowngradeNAOVNanoVibronix0.2935 of 5 stars$4.11-0.2%N/A-85.7%$3.40M$2.56M-3.3420Earnings ReportGap UpCTCXCarmellN/A$0.15-1.3%N/A+35.8%$3.20M$32,839.000.0014Gap UpTTOOT2 BiosystemsN/A$0.15+11.5%$5.00+3,348.3%-97.1%$3.05M$7.68M0.00180Analyst ForecastTIVCTivic Health Systems0.0893 of 5 stars$4.23+7.4%N/A-45.1%$2.59M$780,000.000.0010Positive NewsEarnings ReportBBLGBone Biologics1.28 of 5 stars$0.73-2.6%N/A-37.6%$2.39MN/A0.002Positive NewsNDRAENDRA Life Sciences1.6634 of 5 stars$3.45+5.8%$50.00+1,349.3%-100.0%$1.94MN/A0.0020Gap Up Related Companies and Tools Related Companies GlucoTrack Competitors Heart Test Laboratories Competitors Quoin Pharmaceuticals Competitors Venus Concept Competitors NanoVibronix Competitors Carmell Competitors T2 Biosystems Competitors Tivic Health Systems Competitors Bone Biologics Competitors ENDRA Life Sciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DYNT) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dynatronics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dynatronics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DYNT Stock Free DYNT Stock Alerts